3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Hereditary Sensory and Autonomic Neuropathies
3
Small Cell Lung Carcinoma
2
Uterine Cervical Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neoplasms
1
Metastatic Bladder Urothelial Carcinoma
1
Leiomyosarcoma
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Neuroendocrine
1
Advanced Solid Tumor
1
Interventions
toripalimab
6
Injections
4
tislelizumab
3
sintilimab
3
pembrolizumab
3
cediranib
3
glumetinib
2
apatinib
2
PM 01183
2
Midazolam
2
Irinotecan
2
Gemcitabine
2
Drug Therapy
2
Digoxin
2
Bupropion
2
talazoparib
1
spartalizumab
1
sonidegib
1
sitravatinib
1
serabelisib
1
sapanisertib
1
rucaparib
1
repaglinide
1
penpulimab
1
palbociclib
1
lenvatinib
1
fluzoparib
1
erdafitinib
1
entrectinib
1
dactolisib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Advanced Solid Tumor
×
berzosertib
×
Clear all
NCT02157792
2020-04-01
M6620 First in Human Study
EMD Serono
Phase 1
Completed
200 enrolled